Cover Image
市场调查报告书

成长考察:全球药物研发IT解决方案市场的预测

Growth Insights - Global Pharmaceutical Drug Discovery IT Solutions Market, Forecast to 2020

出版商 Frost & Sullivan 商品编码 599165
出版日期 内容信息 英文 66 Pages
商品交期: 最快1-2个工作天内
价格
Back to Top
成长考察:全球药物研发IT解决方案市场的预测 Growth Insights - Global Pharmaceutical Drug Discovery IT Solutions Market, Forecast to 2020
出版日期: 2017年12月12日 内容信息: 英文 66 Pages
简介

本报告提供全球药物研发IT解决方案市场调查分析,市场概要,促进因素与阻碍因素,预测与趋势,竞争分析,成长机会等系统性信息。

摘要整理

市场定义和概要

促进因素与阻碍因素

  • 推动市场要素
  • 阻碍市场要素

预测与趋势

  • 预测的前提条件
  • 市场工程评量
  • 收益预测
  • 支出额:各功能
  • 地区的明细
  • 收益预测的考察等

主要的市场趋势与对商务的影响

  • 主要趋势与对商务的影响

制药R&D的IT解决方案的引进

  • 各功能的IT引进等级:药物研发和临床开发过程
  • 制药业的IT解决方案引进等级
  • 主要的主张:各大型制药公司
  • 药物研发应用的IT工具引进的亮点
  • 主要IT解决方案的产品/服务的生命周期分析

主要市场成长机会:关注市场区隔

  • 医药品化学市场
  • 基因学
  • 医药品安全性监视、药物安全性IT解决方案

竞争分析

  • 竞争环境
  • 竞争要素评估
  • 关注企业

结论

关于Frost&Sullivan

目录
Product Code: 9AB9/7E

Digitalization in Drug Discovery Presents Significant Growth Opportunities for Healthcare IT Companies

The growing focus of pharmaceutical companies on reducing their drug discovery spending has resulted in companies looking to adopt information technology and informatics solutions to achieve efficiency in their R&D operations. While adoption of IT solutions in clinical research and trial activities is relatively high, drug discovery digital solutions have just started to grow, with companies primarily looking at data analytics and AI-based solutions to the improve efficiency of their research operations.

As adoption of IT solutions grows and vendors develop clarity about customer requirements, the market is expected to witness a transformation in existing product landscape and available opportunities. At present, most market developments and innovations are led by small market participants and start-ups, which are also gaining strong traction from Big Pharma companies. In the near to mid-term, expected expansion plans of large healthcare IT companies are likely to drive market growth and change the overall industry landscape. Despite this, evolution of innovative small companies will continue. This translates into interesting innovations and technology-driven market dynamics.

The global pharmaceutical drug discovery IT solutions market is expected to reach $5.3 billion by 2020 at a compound annual growth rate (CAGR) of 8.9%. Medicinal chemistry solutions are likely to be the dominant IT spending category during the forecast period. The market is highly fragmented with a handful of global participants and many application-focused solution providers.

Key Features

This research publication aims to provide insights on existing and emerging growth opportunities in the global pharmaceutical drug discovery IT solutions market. It covers qualitative and quantitative market insights on overall spend of pharmaceutical companies on drug discovery IT solutions, key market segments, and their spending breakdown, adoption level of IT solutions by top 10 pharmaceutical companies in their drug discovery operations and highlights of their existing operations. The research study further delves into key market segments and associated opportunities, competitive landscape and key participants in the market.

Key Issues Addressed

  • What is the current market landscape and expected growth in the IT spend of pharmaceutical companies in their drug discovery operations?
  • What are the key long-term and short-term opportunities that can be capitalized upon by existing market players and potential entrants?
  • What is the current adoption level of drug discovery IT solutions in the pharmaceutical industry? What initiatives have been taken by Big Pharma companies?
  • What is the current competitive landscape of the market? How are different participants positioned in this segment?
  • What are the key market trends and how are they impacting the overall market landscape?

Table of Contents

1. GROWTH INSIGHTS-GLOBAL PHARMACEUTICAL DRUG DISCOVERY IT SOLUTIONS MARKET, FORECAST TO 2020

Executive Summary

  • Key Findings
  • Market Engineering Measurements
  • Market Engineering Measurements (continued)

Market Definitions and Overview

  • Market Definition-Drug Discovery IT Solutions
  • Market Overview and Landscape
  • Scope and Segmentation
  • Key Questions Addressed in this Study

Drivers and Restraints

  • Market Drivers
  • Drivers for ICT Adoption in Drug Discovery Operations
  • Market Restraints
  • Restraints for ICT Adoption in Drug Discovery Operations

Forecast and Trends

  • Forecast Assumptions-Global Pharmaceutical R&D IT Market
  • Market Engineering Measurements-Pharmaceutical R&D IT Market
  • Revenue Forecast-Pharmaceutical R&D IT Market
  • Global Pharmaceutical R&D IT Spend by Function
  • Global Pharmaceutical R&D IT Market-Regional Breakdown
  • Revenue Forecast Discussion
  • Forecast Assumptions--Global Drug Discovery IT Solutions Market
  • Market Engineering Measurements--Pharmaceutical Drug Discovery IT Solutions Market
  • Revenue Forecast--Pharmaceutical Drug Discovery IT Solutions Market
  • Pharmaceutical Drug Discovery IT Solutions Market Breakdown by Key Segments
  • Revenue Forecast Discussion

Key Market Trends and Their Impact on Business

  • Global Pharmaceutical Drug Discovery IT Solutions--Key Trends and Impact on Business
  • Global Pharmaceutical Drug Discovery IT Solutions--Key Trends Explained
  • Global Pharmaceutical Drug Discovery IT Solutions--Key Trends Explained (continued)
  • Global Pharmaceutical Drug Discovery IT Solutions--Key Trends Explained (continued)

Current Adoption of IT Solutions in Pharmaceutical R&D

  • IT Adoption Level Across Different Functions--Drug Discovery and Clinical Development Process
  • IT Solutions Adoption Levels In the Pharmaceutical Industry
  • Key Initiatives by Big Pharmaceutical Companies
  • Key Initiatives by Big Pharmaceutical Companies (continued)
  • Key Initiatives by Big Pharmaceutical Companies (continued)
  • Highlights of IT Tools Adoption in Drug Discovery Applications
  • Highlights of IT Tool Adoption in Drug Discovery Applications (continued)
  • Product/Service Life Cycle Analysis of Major IT Solutions

Key Market Growth Opportunities--Segments to Watch

  • Segments to Watch--Medicinal Chemistry Market
  • Segments to Watch--Genomics (NGS Informatics Market)
  • Segments to Watch--Genomics (Machine Learning in Genomics)
  • Segments to Watch--Pharmacovigilance and Drug Safety IT Solutions

Competitive Analysis

  • Competitive Environment
  • Competitive Factors Assessment
  • Key Companies to Watch
  • Key Companies to Watch (continued)

Conclusion

  • 3 Key Opportunities
  • Strategic Imperatives
  • Legal Disclaimer

The Frost & Sullivan StoryThe Journey to Visionary Innovation

  • The Frost & Sullivan Story
  • Value Proposition-Future of Your Company & Career
  • Global Perspective
  • Industry Convergence
  • 360° Research Perspective
  • Implementation Excellence
  • Our Blue Ocean Strategy
Back to Top